Checkpoint Therapeutics, Inc. (CKPT): Price and Financial Metrics
CKPT Price/Volume Stats
| Current price | $3.68 | 52-week high | $4.50 |
| Prev. close | $3.65 | 52-week low | $1.38 |
| Day low | $3.57 | Volume | 728,491 |
| Day high | $3.77 | Avg. volume | 779,878 |
| 50-day MA | $3.66 | Dividend yield | N/A |
| 200-day MA | $2.50 | Market Cap | 179.71M |
CKPT Stock Price Chart Interactive Chart >
Checkpoint Therapeutics, Inc. (CKPT) Company Bio
Checkpoint Therapeutics, Inc., an immuno-oncology biopharmaceutical company, focuses on the acquisition, development, and commercialization of non-chemotherapy and immune-enhanced combination treatments for patients with solid tumor cancers. The company was founded in 2014 and is based in New York, New York. Checkpoint Therapeutics, Inc. is a subsidiary of Fortress Biotech, Inc.
CKPT Price Returns
| 1-mo | -12.59% |
| 3-mo | 55.27% |
| 6-mo | 67.27% |
| 1-year | 53.97% |
| 3-year | -86.52% |
| 5-year | -77.42% |
| YTD | 15.00% |
| 2024 | 39.74% |
| 2023 | -55.19% |
| 2022 | -83.57% |
| 2021 | 17.36% |
| 2020 | 54.07% |
Continue Researching CKPT
Here are a few links from around the web to help you further your research on Checkpoint Therapeutics Inc's stock as an investment opportunity:Checkpoint Therapeutics Inc (CKPT) Stock Price | Nasdaq
Checkpoint Therapeutics Inc (CKPT) Stock Quote, History and News - Yahoo Finance
Checkpoint Therapeutics Inc (CKPT) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...